| LR3B001_12mz_21 | Ecl_2022_0628_TPAD_CSF3B_LR3B001_12mz_21 | Ecl_2022_0628_TPAD_CSF3B_LR3B001_12mz_21.mzML | Not available | 2022-06-30 00:21:11 | FSN40228 | Orbitrap Eclipse | Pool | Pool | Pool | Pool | Pool | Pool | Pool | Pool | 4.0 | na | Pool | 3B | Pool | LR3B001 | Pool | Pool | Pool | E06 | Pool |
| LR3B002_12mz_46 | Ecl_2022_0628_TPAD_CSF3B_LR3B002_12mz_46 | Ecl_2022_0628_TPAD_CSF3B_LR3B002_12mz_46.mzML | Not available | 2022-07-02 11:07:19 | FSN40228 | Orbitrap Eclipse | Pool | Pool | Pool | Pool | Pool | Pool | Pool | Pool | 4.0 | na | Pool | 3B | Pool | LR3B002 | Pool | Pool | Pool | F09 | Pool |
| LR3B003_12mz_55 | Ecl_2022_0628_TPAD_CSF3B_LR3B003_12mz_55 | Ecl_2022_0628_TPAD_CSF3B_LR3B003_12mz_55.mzML | Not available | 2022-07-03 06:07:27 | FSN40228 | Orbitrap Eclipse | Pool | Pool | Pool | Pool | Pool | Pool | Pool | Pool | 4.0 | na | Pool | 3B | Pool | LR3B003 | Pool | Pool | Pool | G05 | Pool |
| LR3B004_12mz_66 | Ecl_2022_0628_TPAD_CSF3B_LR3B004_12mz_66 | Ecl_2022_0628_TPAD_CSF3B_LR3B004_12mz_66.mzML | Not available | 2022-07-04 04:50:09 | FSN40228 | Orbitrap Eclipse | Pool | Pool | Pool | Pool | Pool | Pool | Pool | Pool | 4.0 | na | Pool | 3B | Pool | LR3B004 | Pool | Pool | Pool | H02 | Pool |
| TPAD0205_12mz_24 | Ecl_2022_0628_TPAD_CSF3B_TPAD0205_12mz_24 | Ecl_2022_0628_TPAD_CSF3B_TPAD0205_12mz_24.mzML | Not available | 2022-06-30 13:05:44 | FSN40228 | Orbitrap Eclipse | 9022.9 | 1056.3 | 0.12 | 75 | E3_E3 | Cohort 2 | 1 | HC | 1.0 | 481 | January | 3B | 33.8 | TPAD0205 | SAA negative | Female | 243.8 | E08 | 2019 |
| TPAD0209_12mz_28 | Ecl_2022_0628_TPAD_CSF3B_TPAD0209_12mz_28 | Ecl_2022_0628_TPAD_CSF3B_TPAD0209_12mz_28.mzML | Not available | 2022-06-30 22:03:13 | FSN40228 | Orbitrap Eclipse | 13109.9 | 1393.3 | 0.11 | 75 | E2_E3 | Cohort 2 | 1 | HC | 1.0 | 564 | July | 3B | 48.9 | TPAD0209 | SAA negative | Male | 366.8 | E12 | 2019 |
| TPAD0211_12mz_37 | Ecl_2022_0628_TPAD_CSF3B_TPAD0211_12mz_37 | Ecl_2022_0628_TPAD_CSF3B_TPAD0211_12mz_37.mzML | Not available | 2022-07-01 16:03:17 | FSN40228 | Orbitrap Eclipse | 8659.9 | 790.3 | 0.09 | 81 | E3_E4 | Cohort 2 | 1 | HC | 1.0 | 592 | May | 3B | 35.9 | TPAD0211 | SAA negative | Male | 259.8 | F01 | 2019 |
| TPAD0219_12mz_38 | Ecl_2022_0628_TPAD_CSF3B_TPAD0219_12mz_38 | Ecl_2022_0628_TPAD_CSF3B_TPAD0219_12mz_38.mzML | Not available | 2022-07-01 18:14:36 | FSN40228 | Orbitrap Eclipse | 11787.9 | 1532.3 | 0.13 | 76 | E3_E3 | Cohort 1 and Cohort 2 | 1 | HC | 1.0 | 687 | August | 3B | 38.5 | TPAD0219 | SAA negative | Female | 289.8 | F02 | 2016 |
| TPAD0221_12mz_53 | Ecl_2022_0628_TPAD_CSF3B_TPAD0221_12mz_53 | Ecl_2022_0628_TPAD_CSF3B_TPAD0221_12mz_53.mzML | Not available | 2022-07-03 01:41:00 | FSN40228 | Orbitrap Eclipse | 8264 | 1075 | 0.13 | 67.5 | E3_E3 | Cohort 3 | 2 | PDMCI | 3.0 | 141162 | April | 3B | 29.3 | TPAD0456 | SAA positive | Male | 1220 | G02 | 2014 |
| TPAD0233_12mz_41 | Ecl_2022_0628_TPAD_CSF3B_TPAD0233_12mz_41 | Ecl_2022_0628_TPAD_CSF3B_TPAD0233_12mz_41.mzML | Not available | 2022-07-02 00:50:28 | FSN40228 | Orbitrap Eclipse | 6653.9 | 807.3 | 0.12 | 77 | E3_E3 | Cohort 2 | 1 | HC | 1.0 | 851 | June | 3B | 25.4 | TPAD0233 | SAA negative | Male | 180.8 | F05 | 2017 |
| TPAD0247_12mz_18 | Ecl_2022_0628_TPAD_CSF3B_TPAD0247_12mz_18 | Ecl_2022_0628_TPAD_CSF3B_TPAD0247_12mz_18.mzML | Not available | 2022-06-29 17:39:41 | FSN40228 | Orbitrap Eclipse | 12165.9 | 1072.3 | 0.09 | 67 | E3_E3 | Cohort 2 | 1 | HC | 1.0 | 888 | July | 3B | 42.1 | TPAD0247 | SAA negative | Female | 297.8 | E03 | 2017 |
| TPAD0270_12mz_44 | Ecl_2022_0628_TPAD_CSF3B_TPAD0270_12mz_44 | Ecl_2022_0628_TPAD_CSF3B_TPAD0270_12mz_44.mzML | Not available | 2022-07-02 06:42:47 | FSN40228 | Orbitrap Eclipse | 10967.9 | 1019.3 | 0.09 | 66 | E3_E4 | Cohort 2 | 1 | HC | 1.0 | 956 | February | 3B | 42.8 | TPAD0270 | SAA positive | Male | 324.8 | F07 | 2018 |
| TPAD0279_12mz_51 | Ecl_2022_0628_TPAD_CSF3B_TPAD0279_12mz_51 | Ecl_2022_0628_TPAD_CSF3B_TPAD0279_12mz_51.mzML | Not available | 2022-07-02 21:15:03 | FSN40228 | Orbitrap Eclipse | 9865 | 549 | 0.06 | 71 | E4_E4 | Cohort 1 | 1 | HC | 1.0 | 978 | March | 3B | 41.3 | TPAD0279 | SAA negative | Female | 310 | G01 | 2018 |
| TPAD0283_12mz_72 | Ecl_2022_0628_TPAD_CSF3B_TPAD0283_12mz_72 | Ecl_2022_0628_TPAD_CSF3B_TPAD0283_12mz_72.mzML | Not available | 2022-07-04 17:15:20 | FSN40228 | Orbitrap Eclipse | 15365 | 2295 | 0.15 | 79 | E3_E3 | Cohort 1 | 1 | PDCN | 3.0 | 984 | March | 3B | 56.6 | TPAD0283 | SAA positive | Female | 399 | H07 | 2018 |
| TPAD0288_12mz_59 | Ecl_2022_0628_TPAD_CSF3B_TPAD0288_12mz_59 | Ecl_2022_0628_TPAD_CSF3B_TPAD0288_12mz_59.mzML | Not available | 2022-07-03 14:09:45 | FSN40228 | Orbitrap Eclipse | 9515.9 | 1085.3 | 0.11 | 68 | E3_E3 | Cohort 2 | 1 | HC | 1.0 | 992 | May | 3B | 31.9 | TPAD0288 | SAA negative | Male | 280.8 | G08 | 2018 |
| TPAD0297_12mz_68 | Ecl_2022_0628_TPAD_CSF3B_TPAD0297_12mz_68 | Ecl_2022_0628_TPAD_CSF3B_TPAD0297_12mz_68.mzML | Not available | 2022-07-04 09:12:54 | FSN40228 | Orbitrap Eclipse | 5726 | 796 | 0.14 | 65 | E3_E4 | Cohort 1 | 1 | PDCN | 3.0 | 1012 | April | 3B | 21.5 | TPAD0297 | SAA positive | Female | 258 | H04 | 2018 |
| TPAD0301_12mz_27 | Ecl_2022_0628_TPAD_CSF3B_TPAD0301_12mz_27 | Ecl_2022_0628_TPAD_CSF3B_TPAD0301_12mz_27.mzML | Not available | 2022-06-30 19:49:19 | FSN40228 | Orbitrap Eclipse | 10263.9 | 1108.3 | 0.11 | 65 | E3_E3 | Cohort 2 | 1 | HC | 1.0 | 1016 | June | 3B | 37 | TPAD0301 | SAA negative | Female | 271.8 | E11 | 2018 |
| TPAD0304_12mz_73 | Ecl_2022_0628_TPAD_CSF3B_TPAD0304_12mz_73 | Ecl_2022_0628_TPAD_CSF3B_TPAD0304_12mz_73.mzML | Not available | 2022-07-04 19:28:37 | FSN40228 | Orbitrap Eclipse | 10517 | 1432 | 0.14 | 66 | E3_E3 | Cohort 1 | 1 | PDCN | 3.0 | 1024 | April | 3B | 26.8 | TPAD0304 | SAA positive | Female | 221 | H08 | 2018 |
| TPAD0307_12mz_69 | Ecl_2022_0628_TPAD_CSF3B_TPAD0307_12mz_69 | Ecl_2022_0628_TPAD_CSF3B_TPAD0307_12mz_69.mzML | Not available | 2022-07-04 11:23:45 | FSN40228 | Orbitrap Eclipse | 15198.9 | 1941.3 | 0.13 | 66 | E3_E3 | Cohort 2 | 1 | HC | 1.0 | 1030 | August | 3B | 63.2 | TPAD0307 | SAA negative | Female | 478.8 | H05 | 2018 |
| TPAD0308_12mz_26 | Ecl_2022_0628_TPAD_CSF3B_TPAD0308_12mz_26 | Ecl_2022_0628_TPAD_CSF3B_TPAD0308_12mz_26.mzML | Not available | 2022-06-30 17:34:21 | FSN40228 | Orbitrap Eclipse | 13726.9 | 1211.3 | 0.09 | 78 | E2_E3 | Cohort 2 | 1 | HC | 1.0 | 1031 | June | 3B | 72.7 | TPAD0308 | SAA negative | Male | 595.8 | E10 | 2018 |
| TPAD0309_12mz_19 | Ecl_2022_0628_TPAD_CSF3B_TPAD0309_12mz_19 | Ecl_2022_0628_TPAD_CSF3B_TPAD0309_12mz_19.mzML | Not available | 2022-06-29 19:53:06 | FSN40228 | Orbitrap Eclipse | 7743 | 412 | 0.05 | 60 | E4_E4 | Cohort 1 | 1 | AD | 2.0 | 1034 | May | 3B | 129.8 | TPAD0309 | SAA negative | Female | 988 | E04 | 2018 |
| TPAD0316_12mz_74 | Ecl_2022_0628_TPAD_CSF3B_TPAD0316_12mz_74 | Ecl_2022_0628_TPAD_CSF3B_TPAD0316_12mz_74.mzML | Not available | 2022-07-04 21:41:57 | FSN40228 | Orbitrap Eclipse | 7711.9 | 1010.3 | 0.13 | 65 | E3_E4 | Cohort 2 | 1 | HC | 1.0 | 1065 | December | 3B | 31.6 | TPAD0316 | SAA negative | Female | 1109.8 | H09 | 2018 |
| TPAD0339_12mz_48 | Ecl_2022_0628_TPAD_CSF3B_TPAD0339_12mz_48 | Ecl_2022_0628_TPAD_CSF3B_TPAD0339_12mz_48.mzML | Not available | 2022-07-02 15:29:20 | FSN40228 | Orbitrap Eclipse | 13225 | 1679 | 0.13 | 78 | E3_E4 | Cohort 1 | 1 | LBD | 3.0 | 1145 | January | 3B | 45.4 | TPAD0339 | SAA positive | Male | 340 | F11 | 2019 |
| TPAD0362_12mz_58 | Ecl_2022_0628_TPAD_CSF3B_TPAD0362_12mz_58 | Ecl_2022_0628_TPAD_CSF3B_TPAD0362_12mz_58.mzML | Not available | 2022-07-03 11:56:42 | FSN40228 | Orbitrap Eclipse | 9887 | 763.3 | 0.08 | 76 | E4_E4 | Cohort 1 | 1 | HC | 1.0 | 1206 | November | 3B | 57.1 | TPAD0362 | SAA positive | Female | 523.3 | G07 | 2019 |
| TPAD0371_12mz_16 | Ecl_2022_0628_TPAD_CSF3B_TPAD0371_12mz_16 | Ecl_2022_0628_TPAD_CSF3B_TPAD0371_12mz_16.mzML | Not available | 2022-06-29 13:15:21 | FSN40228 | Orbitrap Eclipse | 10871 | 711.3 | 0.07 | 77 | E3_E4 | Cohort 1 | 1 | PDCN | 3.0 | 1223 | October | 3B | 53.4 | TPAD0371 | SAA positive | Female | 349.3 | E01 | 2019 |
| TPAD0375_12mz_61 | Ecl_2022_0628_TPAD_CSF3B_TPAD0375_12mz_61 | Ecl_2022_0628_TPAD_CSF3B_TPAD0375_12mz_61.mzML | Not available | 2022-07-03 18:35:24 | FSN40228 | Orbitrap Eclipse | 12370.9 | 1598.3 | 0.13 | 67 | E3_E4 | Cohort 2 | 1 | HC | 1.0 | 1231 | January | 3B | 59 | TPAD0375 | SAA negative | Female | 409.8 | G10 | 2020 |
| TPAD0377_12mz_56 | Ecl_2022_0628_TPAD_CSF3B_TPAD0377_12mz_56 | Ecl_2022_0628_TPAD_CSF3B_TPAD0377_12mz_56.mzML | Not available | 2022-07-03 08:21:26 | FSN40228 | Orbitrap Eclipse | 9806 | 638.3 | 0.07 | 82 | E3_E4 | Cohort 1 | 1 | AD | 2.0 | 1236 | September | 3B | 113.9 | TPAD0377 | SAA negative | Female | 776.3 | G06 | 2019 |
| TPAD0392_12mz_42 | Ecl_2022_0628_TPAD_CSF3B_TPAD0392_12mz_42 | Ecl_2022_0628_TPAD_CSF3B_TPAD0392_12mz_42.mzML | Not available | 2022-07-02 03:03:58 | FSN40228 | Orbitrap Eclipse | 11496 | 1281.3 | 0.11 | 73 | E2_E3 | Cohort 4 | 1 | MCI | 2.0 | 121060 | February | 3B | 52 | TPAD0392 | SAA negative | Female | 377.3 | F06 | 2012 |
| TPAD0398_12mz_49 | Ecl_2022_0628_TPAD_CSF3B_TPAD0398_12mz_49 | Ecl_2022_0628_TPAD_CSF3B_TPAD0398_12mz_49.mzML | Not available | 2022-07-02 17:40:42 | FSN40228 | Orbitrap Eclipse | 9479 | 1160.3 | 0.12 | 62.9 | na | Cohort 3 | 1 | PDMCI | 3.0 | 121257 | August | 3B | 37.5 | TPAD0398 | SAA positive | Female | 246.3 | F12 | 2012 |
| TPAD0403_12mz_62 | Ecl_2022_0628_TPAD_CSF3B_TPAD0403_12mz_62 | Ecl_2022_0628_TPAD_CSF3B_TPAD0403_12mz_62.mzML | Not available | 2022-07-03 20:48:20 | FSN40228 | Orbitrap Eclipse | 6143 | 756 | 0.12 | 80.2 | E3_E3 | Cohort 3 | 2 | PDCN | 3.0 | 121347 | October | 3B | 30.9 | TPAD0403 | SAA positive | Male | 189 | G11 | 2012 |
| TPAD0435_12mz_25 | Ecl_2022_0628_TPAD_CSF3B_TPAD0435_12mz_25 | Ecl_2022_0628_TPAD_CSF3B_TPAD0435_12mz_25.mzML | Not available | 2022-06-30 15:20:33 | FSN40228 | Orbitrap Eclipse | 4252 | 475 | 0.11 | 70.6 | E3_E3 | Cohort 3 | 2 | PDMCI | 3.0 | 131351 | October | 3B | 32.5 | TPAD0435 | SAA positive | Female | 342 | E09 | 2013 |
| TPAD0438_12mz_65 | Ecl_2022_0628_TPAD_CSF3B_TPAD0438_12mz_65 | Ecl_2022_0628_TPAD_CSF3B_TPAD0438_12mz_65.mzML | Not available | 2022-07-04 02:39:21 | FSN40228 | Orbitrap Eclipse | 9997 | 701.3 | 0.07 | 73 | E3_E4 | Cohort 4 | 1 | MCI | 2.0 | 131432 | December | 3B | 73.8 | TPAD0438 | SAA negative | Male | 488.3 | H01 | 2013 |
| TPAD0452_12mz_23 | Ecl_2022_0628_TPAD_CSF3B_TPAD0452_12mz_23 | Ecl_2022_0628_TPAD_CSF3B_TPAD0452_12mz_23.mzML | Not available | 2022-06-30 10:51:11 | FSN40228 | Orbitrap Eclipse | 4948 | 564 | 0.11 | 65.8 | E3_E4 | Cohort 3 | 2 | PDMCI | 3.0 | 141112 | March | 3B | 16.4 | TPAD0452 | SAA positive | Male | 93 | E07 | 2014 |
| TPAD0453_12mz_77 | Ecl_2022_0628_TPAD_CSF3B_TPAD0453_12mz_77 | Ecl_2022_0628_TPAD_CSF3B_TPAD0453_12mz_77.mzML | Not available | 2022-07-05 04:24:36 | FSN40228 | Orbitrap Eclipse | 15472 | 772.3 | 0.05 | 73 | E3_E4 | Cohort 4 | 1 | MCI | 2.0 | 141124 | March | 3B | 121.5 | TPAD0453 | SAA negative | Male | 779.3 | H12 | 2014 |
| TPAD0456_12mz_52 | Ecl_2022_0628_TPAD_CSF3B_TPAD0456_12mz_52 | Ecl_2022_0628_TPAD_CSF3B_TPAD0456_12mz_52.mzML | Not available | 2022-07-02 23:27:21 | FSN40228 | Orbitrap Eclipse | 9008.9 | 1113.3 | 0.12 | 73 | E3_E3 | Cohort 2 | 1 | HC | 1.0 | 795 | March | 3B | 31.2 | TPAD0221 | SAA negative | Female | 250.8 | G03 | 2017 |
| TPAD0457_12mz_54 | Ecl_2022_0628_TPAD_CSF3B_TPAD0457_12mz_54 | Ecl_2022_0628_TPAD_CSF3B_TPAD0457_12mz_54.mzML | Not available | 2022-07-03 03:53:52 | FSN40228 | Orbitrap Eclipse | 10505 | 1222.3 | 0.12 | 62 | E3_E3 | Cohort 4 | 1 | HC | 1.0 | 141164 | April | 3B | 37.8 | TPAD0457 | SAA negative | Male | 222.3 | G04 | 2014 |
| TPAD0459_12mz_60 | Ecl_2022_0628_TPAD_CSF3B_TPAD0459_12mz_60 | Ecl_2022_0628_TPAD_CSF3B_TPAD0459_12mz_60.mzML | Not available | 2022-07-03 16:22:34 | FSN40228 | Orbitrap Eclipse | 7185 | 613.3 | 0.09 | 68 | E3_E3 | Cohort 4 | 1 | AD | 2.0 | 141171 | April | 3B | 70.3 | TPAD0459 | SAA negative | Female | 532.3 | G09 | 2014 |
| TPAD0464_12mz_17 | Ecl_2022_0628_TPAD_CSF3B_TPAD0464_12mz_17 | Ecl_2022_0628_TPAD_CSF3B_TPAD0464_12mz_17.mzML | Not available | 2022-06-29 15:26:47 | FSN40228 | Orbitrap Eclipse | 12948 | 1512.3 | 0.12 | 82 | E2_E3 | Cohort 4 | 1 | HC | 1.0 | 141198 | May | 3B | 49.1 | TPAD0464 | SAA positive | Male | 387.3 | E02 | 2014 |
| TPAD0477_12mz_76 | Ecl_2022_0628_TPAD_CSF3B_TPAD0477_12mz_76 | Ecl_2022_0628_TPAD_CSF3B_TPAD0477_12mz_76.mzML | Not available | 2022-07-05 02:10:43 | FSN40228 | Orbitrap Eclipse | 7411 | 930.3 | 0.13 | 79 | E2_E3 | Cohort 4 | 1 | HC | 1.0 | 141304 | August | 3B | 21.3 | TPAD0477 | SAA negative | Female | 122.3 | H11 | 2014 |
| TPAD0481_12mz_47 | Ecl_2022_0628_TPAD_CSF3B_TPAD0481_12mz_47 | Ecl_2022_0628_TPAD_CSF3B_TPAD0481_12mz_47.mzML | Not available | 2022-07-02 13:18:21 | FSN40228 | Orbitrap Eclipse | 12737 | 1682 | 0.13 | 79.7 | E3_E3 | Cohort 3 | 2 | PDMCI | 3.0 | 141327 | August | 3B | 43.2 | TPAD0481 | SAA positive | Male | 291 | F10 | 2014 |
| TPAD0485_12mz_40 | Ecl_2022_0628_TPAD_CSF3B_TPAD0485_12mz_40 | Ecl_2022_0628_TPAD_CSF3B_TPAD0485_12mz_40.mzML | Not available | 2022-07-01 22:37:00 | FSN40228 | Orbitrap Eclipse | 6188 | 806 | 0.13 | 79.3 | E3_E4 | Cohort 3 | 2 | HC | 1.0 | 141345 | September | 3B | 27.4 | TPAD0485 | SAA positive | Female | 169 | F04 | 2014 |
| TPAD0493_12mz_39 | Ecl_2022_0628_TPAD_CSF3B_TPAD0493_12mz_39 | Ecl_2022_0628_TPAD_CSF3B_TPAD0493_12mz_39.mzML | Not available | 2022-07-01 20:25:21 | FSN40228 | Orbitrap Eclipse | 4392 | 296 | 0.07 | 72.5 | E2_E3 | Cohort 3 | 2 | PDD | 3.0 | 141365 | September | 3B | 35.8 | TPAD0493 | SAA positive | Male | 207 | F03 | 2014 |
| TPAD0514_12mz_75 | Ecl_2022_0628_TPAD_CSF3B_TPAD0514_12mz_75 | Ecl_2022_0628_TPAD_CSF3B_TPAD0514_12mz_75.mzML | Not available | 2022-07-04 23:56:18 | FSN40228 | Orbitrap Eclipse | 6032.9 | 728.3 | 0.12 | 71 | E2_E3 | Cohort 2 | 1 | HC | 1.0 | 151158 | June | 3B | 33.2 | TPAD0514 | not completed | Female | 216.8 | H10 | 2015 |
| TPAD0524_12mz_67 | Ecl_2022_0628_TPAD_CSF3B_TPAD0524_12mz_67 | Ecl_2022_0628_TPAD_CSF3B_TPAD0524_12mz_67.mzML | Not available | 2022-07-04 07:01:36 | FSN40228 | Orbitrap Eclipse | 12418.9 | 1346.3 | 0.11 | 79 | E3_E3 | Cohort 2 | 1 | HC | 1.0 | 151280 | September | 3B | 49.5 | TPAD0524 | SAA negative | Female | 364.8 | H03 | 2015 |